| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |